Consistent with those anti-cancer effects, several groups have reported that niclosamide suppresses β-catenin mediated canonical Wnt signaling, through means such as inhibited TCF/LEF transcriptional activity and down-regulated pathway target genes, e.g., Axin2 [10,12,16,17]. This evidence concerns the gene AXIN2 and cancer.